Tandem Diabetes Care
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $363,289 | $221,910 | $191,674 | $196,796 |
Gross Profit | 124,653 | 112,794 | 94,672 | 93,295 |
EBITDA | -16,538 | -23,842 | -33,589 | -25,476 |
EBIT | -20,749 | -27,949 | -37,632 | -29,506 |
Net Income | -23,251 | -30,814 | -42,715 | -30,002 |
Net Change In Cash | 363,289 | 221,910 | 191,674 | 196,796 |
Free Cash Flow | 21,540 | -11,741 | -12,453 | -34,699 |
Cash | 49,039 | 47,697 | 58,979 | 58,868 |
Basic Shares | 65,538 | 64,994 | 65,325 | 65,369 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $747,718 | $801,217 | $702,799 | $498,830 |
Gross Profit | 367,690 | 412,986 | 376,215 | 260,520 |
EBITDA | -194,657 | -72,314 | 36,498 | 2,494 |
EBIT | -210,372 | -86,644 | 22,653 | -7,957 |
Net Income | -222,611 | -94,594 | 15,566 | -34,382 |
Net Change In Cash | 747,718 | 801,217 | 702,799 | 498,830 |
Cost of Revenue | 100,509 | -23,585 | 43,051 | |
Free Cash Flow | -83,413 | 7,512 | 87,848 | -7,625 |
Cash | 58,868 | 172,517 | 71,181 | 94,613 |
Basic Shares | 64,968 | 64,146 | 64,349 | 60,990 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.35 |
2024-06-30 | -$0.48 |
2024-03-31 | -$0.63 |
2023-12-31 | -$0.27 |
